What is the price target for CODX stock?
7 analysts have analysed CODX and the average price target is 30.6 USD. This implies a price increase of 1995.89% is expected in the next year compared to the current price of 1.46.
CO-DIAGNOSTICS INC (CODX) Forecast, Price Target & Analyst Ratings
NASDAQ:CODX • US1897632048
Current stock price
1.46 USD
+0.04 (+2.82%)
At close:
1.49 USD
+0.03 (+2.05%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CO-DIAGNOSTICS INC (CODX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$3.83
- Revenue Estimate
- 166.77K
Price Target Details & History
Consensus Price Target and Range
Mean target
$30.60
Upside
+ 1,995.89%
From current price of $1.46 to mean target of $30.60, Based on 7 analyst forecasts
Low
$30.30
Median
$30.60
High
$31.50
Price Target Revisions
1 Month
-20.00%
3 Months
2,300.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for CODX. The average price target is 30.6 USD. This implies a price increase of 1995.89% is expected in the next year compared to the current price of 1.46.
The average price target has been revised upward by 2300% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.71%
CODX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about CODX.
In the previous month the buy percentage consensus was at a similar level.
CODX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-23 | Maxim Group | Downgrade | Buy -> Hold |
| 2025-11-26 | Maxim Group | Initiate | Buy |
| 2025-11-24 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-10-28 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-16 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-19 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-28 | D. Boral Capital | Initiate | Buy |
| 2025-03-28 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-06-17 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-03-15 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2023-12-29 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-11-13 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2023-08-14 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-03-20 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-02-23 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-14 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-12 | Sidoti & Co. | Downgrade | Buy -> Neutral |
| 2022-05-16 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$3.83
- Revenue Estimate
- 166.77K
- Revenue Q2Q
- 231.68%
- EPS Q2Q
- 46.88%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
-2,900.00%
Next Earnings Summary
CODX is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -3.82 USD and the consensus revenue estimate is 166.77K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.812M -80.09% | 3.915M -42.52% | 622.5K -84.10% | 587.52K -5.62% | 17.53M 2,883.73% | 60.552M 245.42% | 139.32M 130.08% | 215.58M 54.74% | 257.78M 19.58% | 305.57M 18.54% | 347.57M 13.74% | |
| EBITDA YoY % growth | -41.476M -302.29% | -38.704M 6.68% | -30.177M 22.03% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -42.706M -268.47% | -40.081M 6.15% | -31.283M 21.95% | -33.404M -6.78% | -38.477M -15.19% | 113.54M 395.08% | 22.732M -79.98% | 67.612M 197.43% | 87.392M 29.26% | 113.06M 29.37% | 133.98M 18.50% | |
| Operating Margin | -626.93% | -1,023.74% | -5,025.45% | -5,685.68% | -219.49% | 187.51% | 16.32% | 31.36% | 33.90% | 37.00% | 38.55% | |
| EPS YoY % growth | -36.30 -163.04% | -33.90 6.61% | -22.54 33.51% | -12.39 45.02% | -12.24 1.23% | -7.04 42.50% | 6.73 195.65% | 19.89 195.45% | 25.40 27.69% | 32.74 28.92% | 36.72 12.15% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -3.83 46.88% | -3.06 55.65% | -2.91 39.44% | -2.75 24.34% |
| Revenue Q2Q % growth | 166.77K 231.68% | 169.83K 4.19% | 175.44K 20.99% | 177.99K -32.58% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.586M -0.40% | -8.96M -11.19% | -9.706M -38.39% | -10.08M -31.59% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
19.06%
EPS Next 5 Year
23.58%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
396.68%
Revenue Next 5 Year
237.24%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
CO-DIAGNOSTICS INC / CODX Forecast FAQ
When does CO-DIAGNOSTICS INC (CODX) report earnings?
CO-DIAGNOSTICS INC (CODX) will report earnings on 2026-05-06.
Can you provide the consensus estimates for CO-DIAGNOSTICS INC next earnings?
The consensus EPS estimate for the next earnings of CO-DIAGNOSTICS INC (CODX) is -3.82 USD and the consensus revenue estimate is 166.77K USD.
Can you provide the analyst count for CO-DIAGNOSTICS INC stock?
The number of analysts covering CO-DIAGNOSTICS INC (CODX) is 7.